Cargando…

Glucose Metabolism, Thyroid Function, and Prolactin Level in Adolescent Patients With First Episode of Schizophrenia and Affective Disorders

Schizophrenia and affective spectrum disorders (ASD) typically begin in adolescence or early adulthood. The pathophysiological mechanisms underlying these disorders are still not fully understood, and recent studies have suggested an involvement of dysfunctions in cardiometabolic and neuroendocrine...

Descripción completa

Detalles Bibliográficos
Autores principales: Petruzzelli, Maria Giuseppina, Marzulli, Lucia, Giannico, Orazio Valerio, Furente, Flora, Margari, Mariella, Matera, Emilia, Margari, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422423/
https://www.ncbi.nlm.nih.gov/pubmed/32848941
http://dx.doi.org/10.3389/fpsyt.2020.00775
_version_ 1783570006675554304
author Petruzzelli, Maria Giuseppina
Marzulli, Lucia
Giannico, Orazio Valerio
Furente, Flora
Margari, Mariella
Matera, Emilia
Margari, Francesco
author_facet Petruzzelli, Maria Giuseppina
Marzulli, Lucia
Giannico, Orazio Valerio
Furente, Flora
Margari, Mariella
Matera, Emilia
Margari, Francesco
author_sort Petruzzelli, Maria Giuseppina
collection PubMed
description Schizophrenia and affective spectrum disorders (ASD) typically begin in adolescence or early adulthood. The pathophysiological mechanisms underlying these disorders are still not fully understood, and recent studies have suggested an involvement of dysfunctions in cardiometabolic and neuroendocrine systems at the onset of both disorders. In this context, we aimed to assess thyroid function, prolactin level, glucose metabolism, and lipid profile in drug naive adolescents, comparing patients with first episode of schizophrenia spectrum disorders (SSD) and patients with ASD. We performed a retrospective chart review from inpatients aged from ten to eighteen years, referred to Child and Adolescent Psychiatric Unit of University of Bari “Aldo Moro” over a period of 4 years, with diagnosis of SSD (n=30) or ASD (n=22), according to Diagnostic and Statistical Manual for Mental Disorders-fifth edition (DSM-5) criteria. Data on serum prolactin, glucose, insulin, total cholesterol, high density lipoprotein cholesterol, low density lipoprotein cholesterol, triglycerides, thyroid stimulating hormone, free triiodothyronin, and free thyroxin were collected, and the insulin resistance (IR) indexes “HOMA1-IR“ and “HOMA2-IR” were calculated. The multivariable linear regression models, adjusting for potential confounding factors (age, sex, and BMI), showed HOMA1-IR (p=0.001), HOMA2-IR (p=0.002), glucose (p=0.004), insulin (p=0.004) and free thyroxin (p<0.001) values higher in the SSD group than in ASD. No others significant differences were found. Our findings suggest the need for a metabolic and endocrine screening at the onset of SSD and ASD, particularly for indexes of IR, that is a testable and treatable risk factor for cardiometabolic diseases. Further studies are required to better understand the role of endocrinological and metabolic dysfunctions at the onset of severe mental illness also considering influencing factors as age, gender, and BMI.
format Online
Article
Text
id pubmed-7422423
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-74224232020-08-25 Glucose Metabolism, Thyroid Function, and Prolactin Level in Adolescent Patients With First Episode of Schizophrenia and Affective Disorders Petruzzelli, Maria Giuseppina Marzulli, Lucia Giannico, Orazio Valerio Furente, Flora Margari, Mariella Matera, Emilia Margari, Francesco Front Psychiatry Psychiatry Schizophrenia and affective spectrum disorders (ASD) typically begin in adolescence or early adulthood. The pathophysiological mechanisms underlying these disorders are still not fully understood, and recent studies have suggested an involvement of dysfunctions in cardiometabolic and neuroendocrine systems at the onset of both disorders. In this context, we aimed to assess thyroid function, prolactin level, glucose metabolism, and lipid profile in drug naive adolescents, comparing patients with first episode of schizophrenia spectrum disorders (SSD) and patients with ASD. We performed a retrospective chart review from inpatients aged from ten to eighteen years, referred to Child and Adolescent Psychiatric Unit of University of Bari “Aldo Moro” over a period of 4 years, with diagnosis of SSD (n=30) or ASD (n=22), according to Diagnostic and Statistical Manual for Mental Disorders-fifth edition (DSM-5) criteria. Data on serum prolactin, glucose, insulin, total cholesterol, high density lipoprotein cholesterol, low density lipoprotein cholesterol, triglycerides, thyroid stimulating hormone, free triiodothyronin, and free thyroxin were collected, and the insulin resistance (IR) indexes “HOMA1-IR“ and “HOMA2-IR” were calculated. The multivariable linear regression models, adjusting for potential confounding factors (age, sex, and BMI), showed HOMA1-IR (p=0.001), HOMA2-IR (p=0.002), glucose (p=0.004), insulin (p=0.004) and free thyroxin (p<0.001) values higher in the SSD group than in ASD. No others significant differences were found. Our findings suggest the need for a metabolic and endocrine screening at the onset of SSD and ASD, particularly for indexes of IR, that is a testable and treatable risk factor for cardiometabolic diseases. Further studies are required to better understand the role of endocrinological and metabolic dysfunctions at the onset of severe mental illness also considering influencing factors as age, gender, and BMI. Frontiers Media S.A. 2020-08-05 /pmc/articles/PMC7422423/ /pubmed/32848941 http://dx.doi.org/10.3389/fpsyt.2020.00775 Text en Copyright © 2020 Petruzzelli, Marzulli, Giannico, Furente, Margari, Matera and Margari http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychiatry
Petruzzelli, Maria Giuseppina
Marzulli, Lucia
Giannico, Orazio Valerio
Furente, Flora
Margari, Mariella
Matera, Emilia
Margari, Francesco
Glucose Metabolism, Thyroid Function, and Prolactin Level in Adolescent Patients With First Episode of Schizophrenia and Affective Disorders
title Glucose Metabolism, Thyroid Function, and Prolactin Level in Adolescent Patients With First Episode of Schizophrenia and Affective Disorders
title_full Glucose Metabolism, Thyroid Function, and Prolactin Level in Adolescent Patients With First Episode of Schizophrenia and Affective Disorders
title_fullStr Glucose Metabolism, Thyroid Function, and Prolactin Level in Adolescent Patients With First Episode of Schizophrenia and Affective Disorders
title_full_unstemmed Glucose Metabolism, Thyroid Function, and Prolactin Level in Adolescent Patients With First Episode of Schizophrenia and Affective Disorders
title_short Glucose Metabolism, Thyroid Function, and Prolactin Level in Adolescent Patients With First Episode of Schizophrenia and Affective Disorders
title_sort glucose metabolism, thyroid function, and prolactin level in adolescent patients with first episode of schizophrenia and affective disorders
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422423/
https://www.ncbi.nlm.nih.gov/pubmed/32848941
http://dx.doi.org/10.3389/fpsyt.2020.00775
work_keys_str_mv AT petruzzellimariagiuseppina glucosemetabolismthyroidfunctionandprolactinlevelinadolescentpatientswithfirstepisodeofschizophreniaandaffectivedisorders
AT marzullilucia glucosemetabolismthyroidfunctionandprolactinlevelinadolescentpatientswithfirstepisodeofschizophreniaandaffectivedisorders
AT giannicooraziovalerio glucosemetabolismthyroidfunctionandprolactinlevelinadolescentpatientswithfirstepisodeofschizophreniaandaffectivedisorders
AT furenteflora glucosemetabolismthyroidfunctionandprolactinlevelinadolescentpatientswithfirstepisodeofschizophreniaandaffectivedisorders
AT margarimariella glucosemetabolismthyroidfunctionandprolactinlevelinadolescentpatientswithfirstepisodeofschizophreniaandaffectivedisorders
AT materaemilia glucosemetabolismthyroidfunctionandprolactinlevelinadolescentpatientswithfirstepisodeofschizophreniaandaffectivedisorders
AT margarifrancesco glucosemetabolismthyroidfunctionandprolactinlevelinadolescentpatientswithfirstepisodeofschizophreniaandaffectivedisorders